EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) announced that patent number 12150931 was issued by the United States Patent and ...
manilatimes1d
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the "Company”), a clinical-stage biopharmaceutical company focused on ...
Adial granted U.S. patent for treatment of alcohol, drug dependence
Adial Pharmaceuticals (ADIL) announced patent number 12150931 was issued on November 26, 2024 by the United States Patent and Trademark Office, ...
ETF Daily News4d
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Increases By 121.8%
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) was the recipient of a significant growth in short interest during the month of November.As of November 15th, there was short interest ...
Morningstar5d
Adial Pharmaceuticals Inc ADIL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Yahoo Finance5d
Adial Pharmaceuticals, Inc. (ADIL)
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
Yahoo Finance5d
Adial Pharmaceuticals, Inc. (ADIL)
At close: 29 November at 1:00 pm GMT-5 ...
pharmaphorum1d
Changing Faces: Pharma and biotech hires from January 2024
Adial taps Board member for C-Suite role. Charlottesville, Virginia-based Adial Pharmaceuticals has added Tony Goodman, already a member of the company’s Board of Directors, to its leadership ...
Investing4d
Adial Pharmaceuticals Inc (ADIL)
Aaaaa Aaaa Aa 25.10 +32.41% ...